ADVFN - Advanced Financial Network.
Free Real-time News Alerts: Tell us which stocks you're watching and we'll send you the latest news as it is released direct to your e-mail.
News alerts
HOME» AMEX » N » CUR Stock Price

Neuralstem Inc. Stock Price

 Neuralstem, Inc. Stock Price
CUR Stock Price
 Neuralstem, Inc. Stock Chart
CUR Stock Chart
 Neuralstem, Inc. Stock News
CUR Stock News
 Neuralstem, Inc. Company Information
CUR Company Information
 Neuralstem, Inc. Stock Trades
CUR Stock Trades
Neuralstem Inc. (CUR)
URL : Neuralstem Inc.
3.77 CUR -0.03
-0.03 (-0.79%)

Company Description : Neuralstem Inc is an biotechnology company, which is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.

Neuralstem Inc. Stock
Share Price3.77
Bid Price-
Ask Price-
% Change-0.79%
Last Change Time17:00:00
Yesterday's Close3.80
Neuralstem Inc. Stock Chart
February 2014 to February 2015
Neuralstem, Inc. Historical Stock Chart February 2014 to February 2015
More CUR Stock Trades »Neuralstem Inc. : Stock Trades Table
TimePriceSizeTypeBid PriceOffer PriceNumberBuy / Sell
16:36:083.75544form t3.763.771,998S
16:31:333.761,426form t3.763.771,997S
16:31:313.775,190form t3.763.771,996B
16:31:303.772,821form t3.763.771,995B
16:12:533.73600form t3.763.771,994S
16:12:173.73700form t3.763.771,993S
16:12:173.731,300form t3.763.771,992S
16:10:413.731,000form t3.763.771,991S
16:09:383.75400form t3.763.771,990S
16:08:083.75400form t3.763.771,989S
Live Intraday Neuralstem Inc. Stock Quote
Friday, 27 February 2015
Neuralstem, Inc. Intraday Stock Chart Friday, 27 February 2015

Neuralstem Inc. and other American Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations